Chronic Diabetic Complications: Current Challenges and Opportunities
Ilias N Migdalis1, Leszek Czupryniak2, Nebojsa Lalic3
1Diabetes Centre, Second Department of Internal Medicine, NIMTS Hospital, 11521 Athens, Greece.
Journal of Clinical Medicine
|February 15, 2022
Summary
This special issue explores chronic diabetic complications, detailing current challenges and future opportunities in diabetes research. It covers a broad spectrum of diabetic issues through original studies and reviews.
Area of Science:
- Endocrinology and Metabolism
- Nephrology
- Ophthalmology
- Neurology
- Cardiology
Background:
- This special issue addresses the multifaceted nature of chronic diabetic complications.
- It encompasses a wide array of research, including original studies and comprehensive reviews.
Discussion:
- The content delves into the current challenges faced in managing and treating diabetic complications.
- It also highlights emerging opportunities for research and clinical intervention.
Key Insights:
- The issue provides a rich scientific overview of diabetic complications.
- It covers diverse areas such as nephropathy, retinopathy, neuropathy, and cardiovascular disease.
Outlook:
- Future research directions and therapeutic strategies are discussed.
- The special issue aims to advance the understanding and management of diabetes-related conditions.
Related Concept Videos
01:15Diabetes: Symptoms, Diagnosis, and Complications
898
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
898
01:15Diabetes: Management and Pharmacotherapy
428
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
428
01:29Chronic Pancreatitis II: Collaborative Care
133
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
133
01:20Pathophysiology of Diabetes
1.5K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.5K
01:22Diabetes Mellitus: Overview and Type I Subtype
3.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.4K
01:25Chronic Kidney Disease I: Introduction
101
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
101